Financials data is unavailable for this security.
View more
Year on year Bausch Health Companies Inc grew revenues 9.91% from 8.76bn to 9.63bn while net income improved from a loss of 592.00m to a smaller loss of 46.00m.
Gross margin | 70.78% |
---|---|
Net profit margin | -0.83% |
Operating margin | 15.96% |
Return on assets | -0.30% |
---|---|
Return on equity | -- |
Return on investment | -0.38% |
More ▼
Cash flow in USDView more
In 2024, Bausch Health Companies Inc increased its cash reserves by 24.84%, or 239.00m. The company earned 1.60bn from its operations for a Cash Flow Margin of 16.59%. In addition the company used 454.00m on investing activities and also paid 868.00m in financing cash flows.
Cash flow per share | 4.34 |
---|---|
Price/Cash flow per share | 2.02 |
Book value per share | -4.38 |
---|---|
Tangible book value per share | -65.31 |
More ▼
Balance sheet in USDView more
Current ratio | 1.35 |
---|---|
Quick ratio | 0.9678 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 1.01 |
More ▼